Pub. Date : 2021 Apr 20
PMID : 33877270
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces cardiovascular event rates after ACS. | Prasugrel Hydrochloride | purinergic receptor P2Y12 | Homo sapiens |
| 2 | The newest P2Y12 inhibitors, prasugrel and ticagrelor, are more potent, with high on-treatment residual platelet reactivity of about 3% vs 30% to 40% with clopidogrel and act within 30 minutes compared with 2 hours for clopidogrel. | Prasugrel Hydrochloride | purinergic receptor P2Y12 | Homo sapiens |